LISA CARR: Open Payments
NPI 1073568630 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 23 payments from 10 companies in 2025. Trend: 2023 $415 · 2024 $418 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $98 |
| PFIZER INC. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Astellas Pharma US Inc | 2 | $50 |
| Dexcom, Inc. | 3 | $47 |
| ABBVIE INC. | 2 | $40 |
| Corcept Therapeutics | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| Bausch Health US, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: NURTEC ODT, CAPLYTA, Ozempic, Veozah, Dexcom G6 Transmitter, QULIPTA, Korlym, Cologuard Collection Kit.
Industry payments across GA — which companies pay providers there.
